Table 2.

Values of SUVs (corrected for bw, lbm, and bsa) of a single lesion, large enough to be selected as target lesion per RECIST, and a whole body total glycolytic activity for tumor burden for two different reconstructions (site standard of care PSF and EARL)

	body weight-corrected SUV						lbm-corrected SUV						bsa-corrected SUV
Statistic	ROI-1	ROI-1	ROI-1 bw (above 40%)	ROI-1 bw (above 40%)	Whole body (above 2.5 SUVbw)	Whole body (above 2.5 SUVbw)	ROI-1	ROI-1	ROI-1 (above 40% SUVlbm)	ROI-1 (above 40.% SUVlbm)	Whole body (above 2.5 SUVlbm)	Whole body (above 2.5 SUVlbm)	ROI-1	ROI-1	ROI-1 (above 40% SUVbsa)	ROI-1 (above 40.% SUVbsa)	Whole body (above 2.5 SUVbsa)	Whole body (above 2.5 SUVbsa)
Reconstruction	PSF	EARL	PSF	EARL	PSF	EARL	PSF	EARL	PSF	EARL	PSF	EARL	PSF	EARL	PSF	EARL	PSF	EARL
Max (SUV) value	17.34	12.26	17.34	12.26	18.04	13.07	14.08	9.95	14.08	9.95	14.64	10.61	0.44	0.31	0.44	0.31	0.46	0.33
% change	41.47	–	–	–	38.04	–	41.47	–	–	–	38.04	–	41.47	–	–	–	38.04	–
Mean (SUV) value	5.94	5.16	11.11	7.65	5.24	4.78	4.82	4.19	9.02	6.21	4.26	3.88	0.15	0.13	0.28	0.19	0.13	0.12
% change	15.14	–	–	–	9.58	–	15.14	–	–	–	9.58	–	15.14	–	–	–	9.58	–
PERCIST SUV peak	12.21	9.29	–	–	–	–	9.91	7.54	–	–	–	–	0.31	0.24	–	–	–	–
% change	31.37	–	–	–	–	–	31.37	–	–	–	–	–	31.37	–	–	–	–	–
Total glycolytic activity (SUV*ml) value	44.83	38.93	25.61	25.44	1329.13	1212.89	36.38	31.6	20.78	20.65	1078.75	984.41	1.14	0.99	0.65	0.65	33.77	30.82
% change	15.14	–	–	–	9.58	–	15.14	–	–	–	9.58	–	15.14	–	–	–	9.58	–
Volume (ml) value	7.54	7.54	2.3	3.33	253.49	253.49	7.54	7.54	2.3	3.33	253.49	253.49	7.54	7.54	2.3	3.33	253.49	253.49